Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow: 24 September 2026 (Including F&O)

  • September 23, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow: 24 September 2026 (Including F&O)

Nifty Pharma closed at 27,152.10, up 0.9% today. Nifty 50 up 0.50%. India VIX 10.37.

Quick Answer: The nifty pharma prediction for tomorrow is constructive for 24 September 2026, with Sun Pharmaceutical Industries as the key constituent to track, tracking broader Nifty 50 direction and F&O positioning into Thursday’s session.

The nifty pharma prediction for tomorrow is in focus after a Wednesday session in which the broader Nifty 50 closed at 23,446.80, up 0.50 percent, and India VIX settled at a genuinely calm 10.37. Pharma stocks posted a solid gain today, with sun pharma and apollo hospitals both contributing to the sector’s strength

This nifty pharma prediction for tomorrow is built from Wednesday’s verified closing data, not speculation about what tomorrow will bring.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are watching sector-specific triggers here, alongside the broader Nifty 50 and Sensex direction heading into 24 September 2026.

Click Here – Get Free Investment Predictions

Nothing in this nifty pharma prediction for tomorrow should be treated as a guarantee, only a working framework for tomorrow’s session.

Also read – Stock Market Prediction for Tomorrow: 24 September 2026

Table of Contents

Toggle
  • Today’s Sector Recap
  • Nifty Pharma F&O Outlook for Tomorrow
  • Key Drivers for Tomorrow
  • Stocks to Watch for Tomorrow
  • Risks to This Prediction
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow?
    • Which stocks matter most for this sector’s outlook tomorrow?
    • Why did Nifty Pharma rise today?
    • Should traders take F&O positions based on this outlook?

Today’s Sector Recap

  • Sun Pharmaceutical Industries gained 1.01 percent, among the key movers in this space on 23 September 2026.
  • The broader Nifty 50 closed at 23,446.80, up 0.50 percent, setting a constructive tone across most sectors.
  • India VIX closed at 10.37, a genuinely calm reading after Wednesday’s sharp fall.

This nifty pharma prediction for tomorrow should be read alongside the support and resistance levels detailed above.

Nifty Pharma F&O Outlook for Tomorrow

For traders active in F&O, this outlook will hinge on open interest build-up and rollover activity in Nifty Pharma futures and options contracts into 24 September 2026. Kunal Singla notes that a stable to falling India VIX would support range-bound F&O positioning, while a reversal higher could see wider intraday swings.

Key Drivers for Tomorrow

  • Pharma stocks posted a solid gain today, with sun pharma and apollo hospitals both contributing to the sector’s strength
  • Crude oil eased further, down 0.69 percent on mcx, extending a soft stretch even as indian equities rallied, a theme relevant across the broader market.
  • India vix fell 5.73 percent to a genuinely calm 10.37, supporting a broadly firm session across nifty 50, sensex and bank nifty, led by a 2.40 percent rally in nifty metal, even as nifty it extended its weak stretch.

Univest’s desk will revisit this nifty pharma prediction for tomorrow once tomorrow’s opening trade confirms direction.

Stocks to Watch for Tomorrow

Stock CMP Relevance
Sun Pharmaceutical Industries See Univest Screener Key Nifty Pharma constituent
Apollo Hospitals Enterprise See Univest Screener Additional Nifty Pharma name to track

Explore Nifty Pharma Stocks on Univest Screeners

Traders relying on this nifty pharma prediction for tomorrow should still size positions to their own risk appetite.

Risks to This Prediction

  • A sharper than expected move in crude oil prices could shift sentiment across all sectors, including Nifty Pharma.
  • Stock-specific news flow in Sun Pharmaceutical Industries or other constituents could override the broader sector trend.
  • A reversal in India VIX could widen intraday ranges beyond the levels discussed here.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces.

As with any nifty pharma prediction for tomorrow, the opening minutes of trade will confirm or challenge the levels discussed here.

Conclusion

The nifty pharma prediction for tomorrow leans constructive into 24 September 2026, with Sun Pharmaceutical Industries and broader Nifty 50 direction as the key variables. Ankit Jaiswal and Kunal Singla will revisit this view once tomorrow’s opening trade confirms direction.

Also read – Nifty 50 Prediction for Tomorrow: 24 September 2026

This nifty pharma prediction for tomorrow is built from Wednesday’s verified closing data, not speculation about what tomorrow will bring.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is constructive, based on Sun Pharmaceutical Industries’s gain of 1.01 percent on 23 September 2026 and the broader Nifty 50 trend.

Which stocks matter most for this sector’s outlook tomorrow?

Ans. Sun Pharmaceutical Industries is one of the key stocks to track, along with the broader Nifty 50 and Sensex direction.

Why did Nifty Pharma rise today?

Ans. Nifty Pharma rose 0.90 percent today, with Sun Pharma’s 1.01 percent gain and Apollo Hospitals’ 2.64 percent surge both contributing to the sector’s strength.

Should traders take F&O positions based on this outlook?

Ans. Any F&O position based on this outlook should factor in position sizing and stop-loss discipline, given how quickly India VIX has moved this week.



Nifty Pharma
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply